Biosyent Inc. (RX) — Net Asset Quality Index
Biosyent Inc. (RX) has a Net Asset Quality Index of 83.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CA$47.79 Million minus total liabilities of CA$7.88 Million yields net assets of CA$39.90 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check RX asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Biosyent Inc. Net Asset Quality Index Over Time (1997–2024)
This chart shows how Biosyent Inc.'s Net Asset Quality Index has evolved across 28 annual periods from 1997 to 2024. As of September 2025, the index stands at 83.5%, representing net assets of CA$39.90 Million against total assets of CA$47.79 Million CAD. See Biosyent Inc. (RX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Biosyent Inc. (1997–2024)
The table below presents the year-by-year Net Asset Quality Index for Biosyent Inc. from 1997 to 2024, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see RX company net worth.
| Year | Quality Index | Net Assets (CAD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 84.6% | CA$35.00 Million | CA$41.36 Million | CA$6.36 Million | ▲ +0.9 pp |
| 2023 | 83.7% | CA$34.76 Million | CA$41.53 Million | CA$6.77 Million | ▲ +1.3 pp |
| 2022 | 82.4% | CA$33.36 Million | CA$40.49 Million | CA$7.12 Million | ▼ -2.5 pp |
| 2021 | 84.9% | CA$31.55 Million | CA$37.17 Million | CA$5.61 Million | ▲ +5.1 pp |
| 2020 | 79.8% | CA$26.80 Million | CA$33.57 Million | CA$6.78 Million | ▼ -3.5 pp |
| 2019 | 83.3% | CA$25.79 Million | CA$30.97 Million | CA$5.17 Million | ▼ -5.2 pp |
| 2018 | 88.5% | CA$27.61 Million | CA$31.19 Million | CA$3.58 Million | ▲ +0.0 pp |
| 2017 | 88.5% | CA$22.21 Million | CA$25.10 Million | CA$2.89 Million | ▲ +1.6 pp |
| 2016 | 86.9% | CA$16.73 Million | CA$19.25 Million | CA$2.52 Million | ▲ +3.7 pp |
| 2015 | 83.2% | CA$12.15 Million | CA$14.61 Million | CA$2.46 Million | ▲ +6.5 pp |
| 2014 | 76.7% | CA$8.16 Million | CA$10.64 Million | CA$2.48 Million | ▼ -3.0 pp |
| 2013 | 79.7% | CA$4.85 Million | CA$6.09 Million | CA$1.24 Million | ▲ +2.0 pp |
| 2012 | 77.7% | CA$2.84 Million | CA$3.65 Million | CA$813.36K | ▲ +4.4 pp |
| 2011 | 73.4% | CA$1.16 Million | CA$1.58 Million | CA$422.37K | ▲ +1.0 pp |
| 2010 | 72.4% | CA$671.02K | CA$927.19K | CA$256.17K | ▼ -8.8 pp |
| 2009 | 81.2% | CA$607.02K | CA$747.73K | CA$140.70K | ▲ +6.0 pp |
| 2008 | 75.2% | CA$854.08K | CA$1.14 Million | CA$282.37K | ▼ -10.5 pp |
| 2007 | 85.7% | CA$1.12 Million | CA$1.31 Million | CA$187.53K | ▲ +1.4 pp |
| 2006 | 84.2% | CA$1.23 Million | CA$1.45 Million | CA$229.20K | ▲ +5.1 pp |
| 2005 | 79.2% | CA$811.46K | CA$1.02 Million | CA$213.28K | ▲ +29.7 pp |
| 2004 | 49.5% | CA$306.20K | CA$618.92K | CA$312.72K | ▼ -29.0 pp |
| 2003 | 78.5% | CA$606.86K | CA$773.39K | CA$166.53K | ▼ -7.2 pp |
| 2002 | 85.6% | CA$621.73K | CA$725.95K | CA$104.22K | ▲ +41.8 pp |
| 2001 | 43.9% | CA$990.86K | CA$2.26 Million | CA$1.27 Million | ▲ +26.0 pp |
| 2000 | 17.9% | CA$210.36K | CA$1.17 Million | CA$964.15K | ▼ -24.9 pp |
| 1999 | 42.9% | CA$600.00K | CA$1.40 Million | CA$800.00K | ▼ -25.9 pp |
| 1998 | 68.8% | CA$1.10 Million | CA$1.60 Million | CA$500.00K | ▲ +23.3 pp |
| 1997 | 45.5% | CA$500.00K | CA$1.10 Million | CA$600.00K | — |